卵巢子宫内膜异位囊肿粘连程度及相关因素分析

Objective To investigate the relationship between degree of endometrioma adhesions and clinical feature, surgical treatment and postoperative recurrence. Methods From Jan 2003 to Mar 2008, 662 patients with endometrioma undergoing laparoscopic ovarian endometrioma excision in Peking Union Medical College Hospital were studied retrospectively. All patients were classified into four groups according to the extent of adhesions: 31 cases in none adhesions group, 123 cases in mild adhesions group (filmy thickness, avascular, easily separated adhesions), 310 cases in moderate adhesions group (less than a half of ovary was adjacent to dense thickness adhesions which was difficult to separate, or above a half of ovary were adjacent to filmy thickness adhesions) and 198 cases in severe adhesions group (above a half of ovary was adjacent to dense thickness, well vascularized adhesions which was difficult to separate, and always involved the other pelvic organs, observed angiogenesis). The comparison of degree, characteristics, period of pain, lab test, surgical management and postoperative recurrence was performed among those above groups. In the mean time, risk factors and multinomial logistic regression were analyzed. Results (1)Clinical characteristics: The incidence of patients with dysmenorrhea, dyspareunia, straining feeling in anus, chronic pelvic pain and the level of CA125 (>35 kU/L) was remarkably higher in moderate-to-severe adhesion groups than in none-to-mild adhesions groups (P=0.000, 0.000, 0.001, 0.006 and 0.000, respectively). Infertility rate were significantly higher in severe adhesions group(15.7%,31/198) than none adhesions group(3.2%,1/31), mild adhesions group(11.4%,14/123) and moderate adhesions group(9.7%,30/310, OR=1.728, P<0.05).(2)Operating time and blood loss: Operating time of each groups was as followed: (37±15) min in none adhesions group, (42±19) min in mild adhesions group, (50±20) min in moderate adhesions group and (63±22) min in severe adhesion group. Blood loss was (23±12) ml in none adhesion group, (31±27) ml in mild adhesion group, (40±32) ml in moderate adhesion group and (70±67) ml in severe adhesions group. Thicker adhesions result in longer operation time and more blood loss. (3)Combined with other disease: The ratio of patients who combined with adenomyosis or deeply infiltrating endometriosis in moderate-to-severer adhesion groups was higher than patients in none-to-mild adhesions groups (OR=3.466, P=0.000). (4) Postoperative recurrence: It was categorized into recurrence of pain and cyst. Moderate-to-severe adhesions was related to higher recurrence rate of pain (OR=1.685,P=0.046), but was irrelevant to recurrence of cyst. Conclusion The more extent of endometrioma adhesions was related to severer pelvic pain symptoms, longer operating time and more blood loss. Postoperative pain recurrence rate was observed in moderate-to-severe adhesion group. Extent of adhesions was irrelevant to cyst recurrence.     

腹部恶性纤维组织细胞瘤28例临床分析

目的探讨腹部恶性纤维组织细胞瘤的诊治方法。方法回顾性分析28例腹部恶性纤维组织细胞瘤的临床表现、影像学特征、病理学特点、治疗方法、疗效和预后。结果28例中17例来源于腹膜后，6例来源于腹腔脏器，3例来源于肠系膜，2例来源于腹壁，主要临床表现为明显消瘦，体重减轻、腹痛和腹部肿块。B超和CT扫描提示腹部占位性病变。肿瘤≥2个24例，单发4例。根治性切除17例，部分切除11例，术后联合化疗16例，联合放疗14例。术后1、3、5年生存率分别为76．9％，26．9％和3．9％。结论腹部恶性纤维组织细胞瘤主要来源于腹膜后，常多发，手术切除是首选的治疗方法，术后联合放化疗，可能改善患者预后。     

载瘤动脉闭塞术治疗颅内巨大动脉瘤的探讨

目的总结和探讨脑血管造影和载瘤动脉闭塞在治疗颅内巨大动脉瘤上的作用及特点。方法60例颅内巨大动脉瘤患者,根据其脑血管造影的特点采取血管内介入方法[可脱式球囊和(或)弹簧圈]闭塞载瘤动脉近端53例、闭塞载瘤动脉两端后孤立动脉瘤7例;其中23例闭塞前先行颅内-外血管搭桥术。结果出院时Rankin评分分级:单纯血管内介入治疗组37例中轻残3例,合并颅内-外血管搭桥术组23例中死亡1例、重残2例。1-6年的影像学随访动脉瘤无复发。结论血管内介入结合颅内-外血管搭桥术闭塞载瘤动脉是治疗颅内巨大动脉瘤的方法之一。     

微创清除术治疗高血压脑出血35例的临床观察

目的观察应用微创清除术救治高血压脑出血的临床疗效。方法对68例高血压脑出血患者采用随机分成内科组(33例,采用控制血压治疗脑水肿等方法)和微创组(35例,采用微创清除术治疗)。采用格拉斯神经功能缺损评分量表及日常生活能力量表评分比较两组的近期(1个月)和远期(6个月)疗效。结果微创组近期优良率(60%)和远期良好率以上(70.3%)高于内科组(30.3%、46.2%%),差异有显著性(P<0.05,P<0.01);微创组近期死亡率(14.3%)明显低于内科组(54.5%),差异有显著性(P<0.01)。结论高血压脑出血采用微创清除术疗效优于内科治疗。     

内吗啡肽在脊髓背角浅层的镇痛机制

内吗啡肽(EM)是μ阿片受体(MOR)的内源性配体。脊髓背角浅层(Ⅰ，Ⅱ层)是阿片类物质调制外周伤害性信息的关键部位，其内含EM和MOR的结构很密集。在脊髓背角浅层，EM可以抑制初级传入末梢释放谷氨酸和P物质，增加中枢内源性镇痛系统的下行投射末梢在脊髓背角释放去甲肾上腺素和5-羟色胺，抑制脊髓背角Ⅱ层(胶状质)兴奋性中间神经元释放神经活性物质。在脊髓背角浅层EM可能通过以上途径实现对外周伤害性信息传递的调制并发挥镇痛作用。     

米非司酮对妊娠中期胎儿心脏超微结构的影响

目的:探讨米非司酮对妊娠中期胎儿心脏超微结构的影响。方法:将计划引产孕妇随机分为两组:对照组(水囊组)10例,实验组(米非司酮+水囊)15例。实验组按孕龄分为实验Ⅰ组(10例,16~22周),实验Ⅱ组(5例,23~28周)。实验组口服米非司酮100mg,连服3天,行水囊引产,对照组只行水囊引产。胎儿娩出后取心肌组织进行样本制备,然后在电镜下观察组织的超微结构。结果:细胞肿胀、空化,细胞膜不完整,闰盘分离,部分细胞连接消失。细胞核多呈不规则形,核内染色质凝聚呈块状,部分细胞核空化,核周围可见脂褐素。大部分肌丝断裂,肌节结构消失,少数可辩残留肌节结构,其间可见少量核糖体,但各带结构不清。线粒体肿胀,高度空化,嵴断裂,细胞基质局部空化。毛细血管内皮细胞肿胀。心肌组织细胞的超微结构有改变,且孕龄越小,超微结构改变越明显。结论:米非司酮可以引发胎儿心脏的缺血缺氧性改变。     

脂膜微泡结合凝血酶原复合物的制备

目的:制备结合凝血酶原复合物(PCC)的阴离子脂膜微泡,评价微泡的理化性质。材料和方法:采用机械振荡直接连接法,分两组(于机械振荡之前或之后加入),制备结合PCC的阴离子脂膜微泡,观察并检测洗涤前后微泡的理化性质。结果:微泡与PCC的结合率及Ⅸ因子活性:两组间比较无明显差异(P>0.05),但洗涤后结合率由洗涤前的95%降为80%,活性由90%降为19%。结论:直接连接法可制备结合PCC的阴离子脂膜微泡,微泡与PCC结合率较高,且洗涤前能保持Ⅸ因子较高的活性。     

计算机导航辅助下人工全膝关节置换术

目的通过分析计算机导航辅助下人工全膝关节置换术中定位与软组织平衡的辅助检测作用,与传统手术进行疗效差异的比较,探讨计算机导航辅助手术的安全性、可靠性及其优势与不足。方法自2004年10月至2005年10月行计算机辅助人工全膝关节置换术18例22膝(导航组),男7例8膝,女11例14膝;年龄35～74岁,平均67岁。导航组采用计算机辅助下行人工全膝关节置换手术。从2003年10月至2004年10月用传统手术的52例中随机抽取17例22膝(非导航组),男5例6膝,女12例16膝;年龄56～78岁,平均65岁。非导航组采用髓内定位杆(股骨)、髓外定位杆(胫骨)定位,常规手术行人工全膝关节置换。全部44膝均为初次置换,两组患者的原始疾病、年龄、HSS评分行配对t检验,差异无统计学意义(P>0.05)。对比两组术前、术后的力线、软组织平衡、并发症、出血量、手术时间及随访情况,进行统计学处理。结果全部病例随访3～12个月,平均10个月。导航组力线误差大多在2°～3°,非导航组3°～6°。软组织平衡角度变量导航组大多在2°以内,非导航组2°～4°;软组织平衡分离变量导航组大多在2～4mm,非导航组5～7mm。导航组出血量大多在550～700ml,非导航组700～900ml;导航组手术时间大多在75～100min,非导航组45～60min。经SPSS10.0统计软件处理,两组在术后力线、软组织平衡角度变量和分离变量、出血量、手术时间,其差异均有统计学意义(P<0.05)。结论计算机导航辅助人工全膝关节置换术,使假体的植入位置更为准确,术后下肢力线和软组织平衡更佳,并能减少出血量,早期疗效满意,但延长了手术时间。     

Artificial bone of porous tricalcium phosphate ceramics and its preliminary clinical application

Summary The authors have prepared the artificial bone of porous tricalcium phosphate ceramics according to an appropriate formula and manufacturing technology. Physical and chemical testing shows that it possesses several distinguishing features: the communicating pores and macro/micropores; mean pore size, 380 μm (from 240 μm to 510 μm); porosity, 46.4 %; and compressive strength, 97.4 kg/cm². It consists of CaO (49.09 %) and P₂O₅ (48.84 %). The testing of its biocompatibility shows that it is devoid of systemic or local toxicity, and free of irritation or foreign body response in tissues, and it does not result in hemolysis or mutation. The new bone readily grows into its pores with direct contact to the implanted material. 11 cases of bone defects were treated with this artificial bone with satisfactory results.